We are live on ! Find out more
LOGC

LogicBio Therapeutics, Inc. Common Stock
LOGC

Delisted

LOGC was delisted on the 15th of November, 2022.

Back to rankings

36 hedge funds and large institutions have $131M invested in LogicBio Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 36 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
36
Holders Change
+36
Holders Change %
–
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
36
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$78.1M
2
RG
Redmile Group
California
+$11M
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$11M
4
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
California
+$11M
5
Franklin Resources
Franklin Resources
California
+$8.46M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$67.3M +$78.1M +6,466,783 New
RG
2
Redmile Group
California
$9.48M +$11M +911,287 New
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$9.46M +$11M +910,000 New
BOTOTLSJU
4
Board of Trustees of The Leland Stanford Junior University
California
$9.46M +$11M +909,244 New
Franklin Resources
5
Franklin Resources
California
$7.28M +$8.46M +700,000 New
SC
6
Samlyn Capital
New York
$5.72M +$6.64M +549,539 New
LPC
7
Lion Point Capital
New York
$5.2M +$6.04M +500,000 New
SFM
8
Sphera Funds Management
Israel
$4.34M +$5.04M +417,625 New
BlackRock
9
BlackRock
New York
$3.93M +$4.56M +377,554 New
Vanguard Group
10
Vanguard Group
Pennsylvania
$2.25M +$2.61M +215,901 New
SCM
11
Sio Capital Management
New York
$1.65M +$1.92M +158,958 New
Northern Trust
12
Northern Trust
Illinois
$873K +$1.01M +83,969 New
Goldman Sachs
13
Goldman Sachs
New York
$675K +$785K +64,949 New
Geode Capital Management
14
Geode Capital Management
Massachusetts
$626K +$727K +60,199 New
State Street
15
State Street
Massachusetts
$625K +$726K +60,118 New
LCM
16
Landscape Capital Management
New Jersey
$578K +$672K +55,597 New
DIM
17
DC Investments Management
Virginia
$543K +$630K +52,174 New
Charles Schwab
18
Charles Schwab
California
$169K +$196K +16,200 New
LCM
19
Laurion Capital Management
New York
$156K +$181K +15,000 New
California State Teachers Retirement System (CalSTRS)
20
California State Teachers Retirement System (CalSTRS)
California
$153K +$178K +14,711 New
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
$146K +$170K +14,068 New
Morgan Stanley
22
Morgan Stanley
New York
$129K +$150K +12,424 New
Deutsche Bank
23
Deutsche Bank
Germany
$115K +$135K +11,188 New
TA
24
Teachers Advisors
New York
$113K +$132K +10,888 New
Wells Fargo
25
Wells Fargo
California
$97K +$114K +9,400 New
1
2

LOGC Hedge Fund Activity: Q4 2018 in Review

36 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in LogicBio Therapeutics, Inc. Common Stock (LOGC) for Q4 2018, worth a combined $131M.

Buyers outnumbered sellers: 36 funds opened new LOGC positions and 0 closed out — a net gain of 36 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was OrbiMed, opening a new position worth an estimated $78.1M.

  • 36 institutional investors held LogicBio Therapeutics, Inc. Common Stock (LOGC) as of Q4 2018, up from 0 in Q3 2018.
  • Funds reported $131M of LogicBio Therapeutics, Inc. Common Stock stock for Q4 2018.
  • 36 funds opened new LogicBio Therapeutics, Inc. Common Stock positions in Q4 2018 and 0 closed out, a net change of +36 holders.
  • The largest LogicBio Therapeutics, Inc. Common Stock buyer in Q4 2018 was OrbiMed, an estimated $78.1M added.

Based on aggregated 13F filings for Q4 2018.